1. Home
  2. PCVX vs RGEN Comparison

PCVX vs RGEN Comparison

Compare PCVX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
    SELLHOLDBUYas of 20 hours ago
  • RGEN
    SELLHOLDBUYas of 20 hours ago
  • Stock Information
  • Founded
  • PCVX 2013
  • RGEN 1981
  • Country
  • PCVX United States
  • RGEN United States
  • Employees
  • PCVX N/A
  • RGEN N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • RGEN Medical/Dental Instruments
  • Sector
  • PCVX Health Care
  • RGEN Health Care
  • Exchange
  • PCVX Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • PCVX 10.6B
  • RGEN 7.6B
  • IPO Year
  • PCVX 2020
  • RGEN N/A
  • Fundamental
  • Price
  • PCVX $88.17
  • RGEN $167.92
  • Analyst Decision
  • PCVX Strong Buy
  • RGEN Buy
  • Analyst Count
  • PCVX 9
  • RGEN 12
  • Target Price
  • PCVX $149.38
  • RGEN $187.44
  • AVG Volume (30 Days)
  • PCVX 1.2M
  • RGEN 521.6K
  • Earning Date
  • PCVX 02-25-2025
  • RGEN 02-19-2025
  • Dividend Yield
  • PCVX N/A
  • RGEN N/A
  • EPS Growth
  • PCVX N/A
  • RGEN N/A
  • EPS
  • PCVX N/A
  • RGEN N/A
  • Revenue
  • PCVX N/A
  • RGEN $633,513,000.00
  • Revenue This Year
  • PCVX N/A
  • RGEN $2.28
  • Revenue Next Year
  • PCVX N/A
  • RGEN $9.88
  • P/E Ratio
  • PCVX N/A
  • RGEN N/A
  • Revenue Growth
  • PCVX N/A
  • RGEN N/A
  • 52 Week Low
  • PCVX $58.10
  • RGEN $113.50
  • 52 Week High
  • PCVX $121.06
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 52.78
  • RGEN 69.43
  • Support Level
  • PCVX $77.52
  • RGEN $150.23
  • Resistance Level
  • PCVX $90.06
  • RGEN $160.64
  • Average True Range (ATR)
  • PCVX 3.83
  • RGEN 7.25
  • MACD
  • PCVX 0.93
  • RGEN 1.50
  • Stochastic Oscillator
  • PCVX 84.93
  • RGEN 98.20

Stock Price Comparison Chart: PCVX vs RGEN

PCVX
RGEN
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025050100150200250300350PCVX VS RGEN

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use